Retreatment with Cisplatin May Provide a Survival Advantage for Children with Relapsed/Refractory Hepatoblastoma: An Institutional Experience

SIMPLE SUMMARY: Treatment of hepatoblastoma at time of first diagnosis has evolved to include well described chemotherapy regimens along with surgical resection, resulting in improved outcomes. Unfortunately, in cases of recurrent or refractory disease, there is no standard of care to employ and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Somers, Katherine M., Tabbouche, Rachel Bernstein, Bondoc, Alexander, Towbin, Alexander J., Ranganathan, Sarangarajan, Tiao, Greg, Geller, James I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416880/
https://www.ncbi.nlm.nih.gov/pubmed/37568737
http://dx.doi.org/10.3390/cancers15153921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416880/
https://www.ncbi.nlm.nih.gov/pubmed/37568737
http://dx.doi.org/10.3390/cancers15153921

Ejemplares similares